Gongwin Biopharm Holdings Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was TWD 0 compared to TWD 248,000 a year ago. Operating loss was TWD 49.346 million compared to TWD 51.095 million a year ago. Net loss was TWD 37.931 million compared to TWD 42.859 million a year ago. Basic loss per share was TWD 0.37 compared to TWD 0.42 a year ago.